A new method for adjusting CYP1A2 metabolic ratios from uncontrolled dietary caffeine intake

被引：0
|
作者：
Jetter, A. [1 ]
Urry, E. [2 ]
Landolt, H. P. [2 ]
机构：
[1] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland
[2] Univ Zurich, Inst Pharmacol & Toxicol, Human Sleep Psychopharmacol Lab, Zurich, Switzerland
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P240
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] CAFFEINE AS A METABOLIC PROBE - A COMPARISON OF THE METABOLIC RATIOS USED TO ASSESS CYP1A2 ACTIVITY
    NOTARIANNI, LJ
    OLIVER, SE
    DOBROCKY, P
    BENNETT, PN
    SILVERMAN, BW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (01) : 65 - 69
  • [2] Caffeine intake and CYP1A2 variability in Parkinson's disease
    Tan, E. K.
    Chua, E.
    Tan, L.
    Zhao, Y.
    MOVEMENT DISORDERS, 2007, 22 : S137 - S138
  • [3] Association of caffeine intake and CYP1A2 genotype with ovarian cancer
    Goodman, MT
    Tung, KH
    McDuffie, K
    Wilkens, LR
    Donlon, TA
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2003, 46 (01): : 23 - 29
  • [4] Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension
    Guessous, Idris
    Dobrinas, Maria
    Kutalik, Zoltan
    Pruijm, Menno
    Ehret, Georg
    Maillard, Marc
    Bergmann, Sven
    Beckmann, Jacques S.
    Cusi, Daniele
    Rizzi, Federica
    Cappuccio, Franco
    Cornuz, Jacques
    Paccaud, Fred
    Mooser, Vincent
    Gaspoz, Jean-Michel
    Waeber, Gerard
    Burnier, Michel
    Vollenweider, Peter
    Eap, Chin B.
    Bochud, Murielle
    HUMAN MOLECULAR GENETICS, 2012, 21 (14) : 3283 - 3292
  • [5] Oxidation of caffeine by CYP1A2: Isotope effects and metabolic switching
    Regal, KA
    Kunze, KL
    Peter, RM
    Nelson, SD
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) : 1837 - 1844
  • [6] Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin
    Haertter, Sebastian
    Korhonen, Tuomas
    Lundgren, Stefan
    Rane, Anders
    Tolonen, Ari
    Turpeinen, Miia
    Laine, Kari
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 (04) : 300 - 304
  • [7] CAFFEINE AS A METABOLIC PROBE - A COMPARISON OF THE METABOLIC RATIOS USED TO ASSESS CYP1A2 ACTIVITY (VOL 39, PG 65, 1995)
    NOTARIANNI, LJ
    OLIVER, SE
    DOBROCKY, P
    BENNETT, PN
    SILVERMAN, BW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (01) : U7 - U7
  • [8] Caffeine Impact on Metabolic Syndrome Components Is Modulated by a CYP1A2 Variant
    Platt, Daniel E.
    Ghassibe-Sabbagh, Michella
    Salameh, Pascale
    Salloum, Angelique K.
    Haber, Marc
    Mouzaya, Francis
    Gauguier, Dominique
    Al-Sarraj, Yasser
    El-Shanti, Hatem
    Zalloua, Pierre A.
    Abchee, Antoine B.
    ANNALS OF NUTRITION AND METABOLISM, 2016, 68 (01) : 1 - 11
  • [9] Caffeine Metabolic Ratios for the In Vivo Evaluation of CYP1A2, N-acetyltransferase 2, Xanthine Oxidase and CYP2A6 Enzymatic Activities
    Hakooz, Nancy M. Kh.
    CURRENT DRUG METABOLISM, 2009, 10 (04) : 329 - 338
  • [10] Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity
    Härtter, S
    Nordmark, A
    Rose, DM
    Bertilsson, L
    Tybring, G
    Laine, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) : 679 - 682
12345